Prostate cancer has jumped back into the spotlight after the latest news about Joe Biden’s worsening condition, and that attention comes with a hard truth: this disease is common, serious, and often misunderstood. His son’s description of the illness as “very painful” and “very debilitating in many respects” puts a human face on what can happen when the cancer moves beyond the prostate and starts affecting the body in a much bigger way.
Biden’s diagnosis was first disclosed in 2025 after doctors found a small nodule during a routine exam, and the condition was later described as a more aggressive form of the disease that was still hormone-sensitive. Since then, he has undergone hormone therapy and radiation, while doctors and family members have had to navigate a disease that can shift quickly from manageable to far more complicated.
That progression is exactly why prostate cancer gets so much medical attention. It usually starts in the prostate gland, a small organ that plays a big role in male reproductive health, and it can stay quiet for a long time before anyone notices something is wrong.
The numbers alone are enough to grab attention. The American Cancer Society expects more than 333,000 new cases in the U.S. in 2026, along with more than 36,000 deaths, and roughly one in eight men will face the disease during their lifetime.
Risk climbs with age, which is one reason doctors stay focused on older men. Most cases are diagnosed in men 65 and older, and the average age at diagnosis is 67, while men under 40 are rarely hit by it.
When prostate cancer is found early, it often does not announce itself with dramatic symptoms. Instead, it may show up as urinary trouble, a weak stream, or suddenly needing to go to the bathroom more often than usual.
Some men notice blood in the urine or other bodily fluids, while more advanced disease can bring a very different kind of pain. Once the cancer spreads, it can show up in the hips, back, ribs, chest, and other areas, and it may also cause fatigue, weakness, weight loss, erectile dysfunction, or trouble with bladder and bowel control.
That is why screening matters, even when the topic is uncomfortable. The U.S. Preventive Services Task Force says men between 55 and 69 should have the option of PSA-based screening, but the choice should come after a real conversation with a clinician about the tradeoffs.
Screening can save lives, but it is not a perfect system. Some men get false alarms, some are diagnosed with cancers that may never have caused harm, and others face treatment side effects that can change daily life in a big way.
Researchers are still working on better ways to catch the disease earlier and with less guesswork. New approaches, including non-invasive urine testing, are being studied as doctors look for tools that can spot aggressive cancer without piling on unnecessary procedures.
Survival depends heavily on how far the cancer has spread. Localized and regional prostate cancer carries a five-year survival rate of 99% or higher, but once it reaches distant parts of the body, that number drops sharply.
The reality is that prostate cancer can look very different from one patient to another, and no chart tells the whole story. Age, overall health, how fast the disease advances, and how well it responds to treatment all shape what comes next, which is why the conversation around screening, symptoms, and treatment keeps getting louder.
